You can view the research column published every month by SMC Laboratories.
2025.02.02
We would like to introduce the Liposaccharide-induced Acute Lung Injury model (LPS model) – an ARDS model that…
2025.02.02
We would like to introduce the Liver Orthotopic Xenograft mouse model – a cancer model that also allows the ev…
2025.02.02
We would like to share with you about our experience evaluating farnesoid X receptor (FXR) agonists in the wor…
2025.02.02
We would like to introduce today the world’s first mouse model that induces liver cancer from nonalcohol…
2025.02.02
It has been reported that various metabolic diseases are a factor in COVID-19 severity, and an increased risk …
2025.02.02
We would like to introduce an update regarding the relationship between pulmonary fibrosis and COVID-19, which…
2025.02.02
We would like to introduce Galectin-3, a potential therapeutic target molecule in Idiopathic Pulmonary Fibrosi…
2025.02.02
We would like to introduce the versatility of our proprietary NASH-HCC model (“STAM™ mice”). We have pr…
2025.02.02
Today, we would like to introduce to you a study published by our client, MRM Health, in which they used our p…
2025.02.02
Today’s topic is Effective and Safe Nutritional Supplements for NASH Management. I am writing you to int…
We can help you advance your research.